Long-Term Follow-Up of Children in the HIVNET 012 Perinatal HIV Prevention Trial: Five-Year Growth and Survival.

Publication Type:

Journal Article

Source:

Journal of acquired immune deficiency syndromes (1999), Volume 64, Issue 5, p.464-71 (2013)

Keywords:

2013, November 2013, Vaccine and Infectious Disease Division

Abstract:

To describe 5-year growth, survival, and long-term safety among children exposed to nevirapine or zidovudine in an African perinatal prevention trial, HIVNET 012.